- 25CN-NBOH
- N-(2-Hydroxybenzyl)-4-cyano-2,5-dimethoxyphenethylamine
- 2C-CN-NBOH
- 4-(2-{[(2-Hydroxyphenyl)methyl]amino}ethyl)-2,5-dimethoxybenzonitrile
- 4-{2-[(2-Hydroxybenzyl)amino]ethyl}-2,5-dimethoxybenzonitrile
Hansen, M. Design and synthesis of selective serotonin receptor agonists for positron emission tomography imaging of the brain Ph. D. Thesis, University of Copenhagen, 16 Dec 2012. 7.9 MB. #2.46 NMR
Fantegrossi, WE; Gray, BW; Bailey, JM; Smith, DA; Hansen, M; Kristensen, JL. Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl)ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT2A receptors, in mice Psychopharmacology, 1 Mar 2015, 232 (6), 1039-1047. 545 kB. https://doi.org/10.1007/s00213-014-3739-3
Halberstadt, AL. Pharmacology and Toxicology of N-Benzylphenethylamine (“NBOMe”) Hallucinogens In Neuropharmacology of New Psychoactive Substances (NPS): The Science Behind the Headlines; Halberstadt, AL; Vollenweider, FX; Nichols, DE, Eds., Springer, 18 Jan 2017; pp 283-311. 826 kB. https://doi.org/10.1007/7854_2016_64
Jensen, AA; McCorvy, JD; Leth-Petersen, S; Bundgaard, C; Liebscher, G; Kenakin, TP; Bräuner-Osborne, H; Kehler, J; Kristensen, JL. Detailed characterization of the in vitro pharmacological and pharmacokinetic properties of N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine (25CN-NBOH), a highly selective and brain-penetrant 5-HT2A receptor agonist J. Pharmacol. Exp. Ther., 1 Jun 2017, 361 (3), 441–453. 4.1 MB. https://doi.org/10.1124/jpet.117.239905 #25CN-NBOH, 1
Hansen, M; Phonekeo, K; Paine, JS; Leth-Petersen, S; Begtrup, M; Bräuner-Osborne, H; Kristensen, JL. Synthesis and structure–activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists ACS Chem. Neurosci., 19 Mar 2014, 5 (3), 243-249. 21.5 MB. https://doi.org/10.1021/cn400216u #6b NMR
Nichols, DE. Chemistry and structure–activity relationships of psychedelics In Behavioral Neurobiology of Psychedelic Drugs; Halberstadt, AL; Vollenweider, FX; Nichols, DE, Eds., Springer, 1 Jan 2017; pp 1-43. 2.6 MB. https://doi.org/10.1007/7854_2017_475 #73
Halberstadt, AL; Geyer, MA. Effect of hallucinogens on unconditioned behavior In Behavioral Neurobiology of Psychedelic Drugs; Halberstadt, AL; Vollenweider, FX; Nichols, DE, Eds., Springer, 1 Jan 2017; pp 159-199. 879 kB. https://doi.org/10.1007/7854_2016_466
Chapman, SJ. Novel Psychoactive Spectra: NMR of (mostly) Novel Psychoactive Substances BLOTTER, 25 Jun 2018, 3 (2). https://doi.org/10.16889/isomerdesign-6 #25CN-NBOH NMR
Poulie, CBM; Jensen, AA; Halberstadt, AL; Kristensen, JL. DARK Classics in Chemical Neuroscience: NBOMes ACS Chem. Neurosci., 2 Dec 2020, 11 (23), 3860-3869. 860 kB. https://doi.org/10.1021/acschemneuro.9b00528 #25CN-NBOH
Jensen, AA; Halberstadt, AL; Märcher-Rørsted, E; Odland, AU; Chatha, M; Speth, N; Liebscher, G; Hansen, M; Bräuner-Osborne, H; Palner, M; Andreasen, JT; Kristensen, JL. The selective 5-HT2A receptor agonist 25CN-NBOH: Structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of [3H]25CN-NBOH Biochem. Pharmacol., 1 Jul 2020, 177 113979. 2.3 MB. https://doi.org/10.1016/j.bcp.2020.113979 #1 NMR
Marcher-Rørsted, E; Halberstadt, AL; Klein, AK; Chatha, M; Jademyr, S; Jensen, AA; Kristensen, JL. Investigation of the 2,5-dimethoxy motif in phenethylamine serotonin 2A receptor agonists ACS Chem. Neurosci., 26 Mar 2020, 11 (9), 1238-1244. 3.8 MB. https://doi.org/10.1021/acschemneuro.0c00129 #19 LC,MS,NMR
Kim, K; Che, T; Panova, O; DiBerto, JF; Lyu, J; Krumm, BE; Wacker, D; Robertson, MJ; Seven, AB; Nichols, DE; Shoichet, BK; Skiniotis, G; Roth, BL. Structure of a hallucinogen-activated Gq-coupled 5-HT2A serotonin receptor Cell, 1 Sep 2020, 182 (6), 1574-1588.e19. 12.2 MB. https://doi.org/10.1016/j.cell.2020.08.024 #25CN-NBOH
Märcher-Rørsted, E; Nykodemová, J; Kristensen, JL. An improved, scalable synthesis of the selective serotonin 2A receptor agonist 25CN-NBOH SynOpen, 1 Jun 2021, 05 (02), 158–160. 1.7 MB. https://doi.org/10.1055/a-1524-4439 #1 LC,MS,NMR
Rørsted, EM; Jensen, AA; Kristensen, JL. 25CN‐NBOH: A selective agonist for in vitro and in vivo investigations of the serotonin 2A receptor ChemMedChem, 21 Aug 2021, 16 (21), 3263-3270. 1.7 MB. https://doi.org/10.1002/cmdc.202100395 #25CN-NBOH
Pottie, E; Kupriyanova, OV; Brandt, AL; Laprairie, RB; Shevyrin, VA; Stove, CP. Serotonin 2A receptor (5-HT2AR) activation by 25H-NBOMe positional isomers: In vitro functional evaluation and molecular docking ACS Pharmacol. Transl. Sci., 9 Apr 2021, 4 (2), 479–487. 2.9 MB. https://doi.org/10.1021/acsptsci.0c00189 #25CN-NBOH
Cumming, P; Scheidegger, M; Dornbierer, D; Palner, M; Quednow, BB; Martin-Soelch, C. Molecular and functional imaging studies of psychedelic drug action in animals and humans Molecules, 1 Jan 2021, 26 (9), 2451. 3.5 MB. https://doi.org/10.3390/molecules26092451 #13
Kristensen, JL; Jensen, AA; Märcher-Rørsted, E; Leth-Petersen, S. 5-HT2A agonists for use in treatment of depression Patent US 2021/0137908 A1, 13 May 2021. 8.2 MB. #25CN-NBOH LC,MS,NMR,TLC
Kruegel, AC. Phenalkylamines and methods of making and using the same Patent WO 2022/192781 A1, 15 Sep 2022. 22.8 MB. #64 LC,MS,NMR
Marcher-Rørsted, E; Nykodemová, J; Harpsøe, K; Jensen, AA; Kristensen, JL. Introducing conformational restraints on 25CN-NBOH: A selective 5-HT2A receptor agonist ACS Med. Chem. Lett., 9 Mar 2023, 14 (3), 319–325. 8.9 MB. https://doi.org/10.1021/acsmedchemlett.3c00014 #1 LC,MS,NMR,TLC
Poulie, CBM; Pottie, E; Simon, IA; Harpsøe, K; D’Andrea, L; Komarov, IV; Gloriam, DE; Jensen, AA; Stove, CP; Kristensen, JL. Discovery of β-arrestin-biased 25CN-NBOH-derived 5-HT2A receptor agonists J. Med. Chem., 22 Sep 2022, 65 (18), 12031–12043. 9.5 MB. https://doi.org/10.1021/acs.jmedchem.2c00702 #6a LC,MS,NMR
Wallach, J; Cao, AB; Calkins, MM; Heim, AJ; Lanham, JK; Bonniwell, EM; Hennessey, JJ; Bock, HA; Anderson, EI; Sherwood, AM; Morris, H; de Klein, R; Klein, AK; Cuccurazzu, B; Gamrat, J; Fannana, T; Zauhar, R; Halberstadt, AL; McCorvy, JD. Identification of 5-HT2A receptor signaling pathways responsible for psychedelic potential bioRxiv, 31 Jul 2023, 2023.07.29.551106. 9.8 MB. https://doi.org/10.1101/2023.07.29.551106 #25CN-NBOH LC,MS,NMR
Chen, Z; Fan, L; Wang, H; Yu, J; Lu, D; Qi, J; Nie, F; Luo, Z; Liu, Z; Cheng, J; Wang, S. Structure-based design of a novel third-generation antipsychotic drug lead with potential antidepressant properties Nat. Neurosci., 1 Jan 2022, 25 (1), 39–49. 14.2 MB. https://doi.org/10.1038/s41593-021-00971-w #25CN-NBOH
Duan, W; Cao, D; Wang, S; Cheng, J. Serotonin 2A receptor (5-HT2AR) agonists: Psychedelics and non-hallucinogenic analogues as emerging antidepressants Chem. Rev., 10 Jan 2024, 124 (1), 124–163. 12.6 MB. https://doi.org/10.1021/acs.chemrev.3c00375 #104